Agomab Therapeutics NV (‘Agomab’) today announced that interim data from the ongoing STENOVA1 Phase 2a clinical trial for AGMB-129, an oral gastro-intestinal (GI)-restricted small molecule inhibitor ...

Key Laboratory of Traditional Chinese Korean Medicine Research (Yanbian University) of State Ethnic Affairs Commission, College of Pharmacy, Yanbian University, Yanji, Jilin Province 133002, China Key ...

Results from the STENOVA trial of AGMB-129, a gut-restricted oral small molecule inhibitor of ALK5, are due early next year. Meanwhile, Agomab will also use some of the proceeds for further ...

Canada must act quickly to attract the American medical and scientific professionals who no longer feel valued in Trump's United States with its mass layoffs and the elimination of health programs and ...

ESG Book, in partnership with BCG, today announced the launch of LEO, a purpose-built solution for smarter, faster, and more ...

Calcitonin gene-related peptide (CGRP) inhibitors are now considered a first-line treatment used to treat and prevent migraines. There are two types of CGRP medications: monoclonal antibodies and ...

Join MIMS now and pay nothing for the first 30 days Join GPOnline now and pay nothing for the first 30 days ...